Revisiting ageless antiques; synthesis, biological evaluation, docking simulation and mechanistic insights of 1,4-Dihydropyridines as anticancer agents
作者:Peter A. Sidhom、Eman El-Bastawissy、Abeer A. Salama、Tarek F. El-Moselhy
DOI:10.1016/j.bioorg.2021.105054
日期:2021.9
antitumor activity against lung cancer A549 (GI%= 83.02%), more powerful than both cisplatin and doxorubicin. Compound 11b exhibited an exceptional anticancer activity against lung cancer cell line (A549) as its GI50 in nanomolar was (540 nM) with a 9-fold increase greater than cisplatin (GI50 = 4.93 µM) and with a selectivity index = 131 to cancer cells over normal cells. Further mechanistic investigations
历史悠久的 DHP 核是大约 130 年前由 Arthur Hantzsch 偶然发现的,至今仍被认为是各种药理活动的隐藏宝藏。使用方便的一锅 Hantzsch 合成法合成了 21 种 DHP 类似物,用于筛选作为抗癌剂。最初,在对18个癌症细胞系中的体外抗增殖单剂量表明,化合物11B和图8F分别为关于它们的抗肿瘤作用(GI%平均值= 66.40%和50.42%,相应地)与顺铂相比(GI的最高级候选% 平均值 = 65.58%)和多柔比星(GI% 平均值 = 74.56%)。值得注意的是,化合物11b显示出显着的MDA-MB-468抗癌活性(GI%=80.81%),高于顺铂(64.44%)和多柔比星(76.72%),对肺癌A549具有很强的抗肿瘤活性(GI%=83.02%),比顺铂和阿霉素更有效。化合物11b对肺癌细胞系 (A549) 表现出优异的抗癌活性,因为其纳摩尔GI 50为 (540